These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10963897)

  • 1. Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine.
    Xiao XQ; Lee NT; Carlier PR; Pang Y; Han YF
    Neurosci Lett; 2000 Sep; 290(3):197-200. PubMed ID: 10963897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury.
    Xiao XQ; Wang R; Tang XC
    J Neurosci Res; 2000 Sep; 61(5):564-9. PubMed ID: 10956426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells.
    Zhang HY; Tang XC
    Neurosci Lett; 2000 Sep; 292(1):41-4. PubMed ID: 10996445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells.
    Wang R; Zhou J; Tang XC
    Brain Res Mol Brain Res; 2002 Oct; 107(1):1-8. PubMed ID: 12414117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.
    Wang H; Carlier PR; Ho WL; Wu DC; Lee NT; Li CP; Pang YP; Han YF
    Neuroreport; 1999 Mar; 10(4):789-93. PubMed ID: 10208549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuating effect of a traditional korean formulation, Paeng-Jo-Yeon-Nyeon-Baek-Ja-In-Hwan (PJBH), on hydrogen peroxide-induced injury in PC12 cells.
    Koo BS; Kim YK; Park KS; Chung KH; Kim CH
    Phytother Res; 2004 Jun; 18(6):488-93. PubMed ID: 15287076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A water extract of Curcuma longa L. (Zingiberaceae) rescues PC12 cell death caused by pyrogallol or hypoxia/reoxygenation and attenuates hydrogen peroxide induced injury in PC12 cells.
    Koo BS; Lee WC; Chung KH; Ko JH; Kim CH
    Life Sci; 2004 Sep; 75(19):2363-75. PubMed ID: 15350833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation.
    Zhou J; Fu Y; Tang XC
    Neurosci Lett; 2001 Jun; 306(1-2):53-6. PubMed ID: 11403956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
    Svensson AL; Nordberg A
    Neuroreport; 1998 May; 9(7):1519-22. PubMed ID: 9631459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of huperzine A on beta-amyloid(25-35) induced oxidative injury in rat pheochromocytoma cells.
    Xiao XQ; Wang R; Han YF; Tang XC
    Neurosci Lett; 2000 Jun; 286(3):155-8. PubMed ID: 10832008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury.
    Xiao XQ; Yang JW; Tang XC
    Neurosci Lett; 1999 Nov; 275(2):73-6. PubMed ID: 10568502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist.
    Li CY; Wang H; Xue H; Carlier PR; Hui KM; Pang YP; Li ZW; Han YF
    Neuroreport; 1999 Mar; 10(4):795-800. PubMed ID: 10208550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.
    Xie SS; Lan JS; Wang XB; Jiang N; Dong G; Li ZR; Wang KD; Guo PP; Kong LY
    Eur J Med Chem; 2015 Mar; 93():42-50. PubMed ID: 25656088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.
    Chao X; He X; Yang Y; Zhou X; Jin M; Liu S; Cheng Z; Liu P; Wang Y; Yu J; Tan Y; Huang Y; Qin J; Rapposelli S; Pi R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6498-502. PubMed ID: 22981331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tetracyclic tacrine analogs containing pyrano[2,3-c]pyrazole: efficient synthesis, biological assessment and docking simulation study.
    Khoobi M; Ghanoni F; Nadri H; Moradi A; Pirali Hamedani M; Homayouni Moghadam F; Emami S; Vosooghi M; Zadmard R; Foroumadi A; Shafiee A
    Eur J Med Chem; 2015 Jan; 89():296-303. PubMed ID: 25462245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
    Bautista-Aguilera ÓM; Ismaili L; Iriepa I; Diez-Iriepa D; Chabchoub F; Marco-Contelles J; Pérez M
    Chem Rec; 2021 Jan; 21(1):162-174. PubMed ID: 33169934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
    Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
    Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.